Overview Financials News + Filings Key Docs Charts Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Inv. presentation
Quarterly results
|
|
Nuvectra Corp (NVTR)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 11/13/2019 |
GN
| Nuvectra® maintient la prise en charge de ses patients actuels dotés de l'implant Algovita® alors que la société dépose volontairement une requête en vertu du chapitre 11 |
| 11/13/2019 |
GN
| Nuvectra® unterstützt weiterhin bestehende Patienten mit dem Algovita®-Implantat, während das Unternehmen freiwillig ein Verfahren gemäß Chapter 11 beantragt |
| 11/13/2019 |
GN
| Nuvectra®???????11???????Algovita®????????? |
| 11/13/2019 |
GN
| Nuvectra® ???? 11 ?????,????? Algovita® ??????? |
| 11/13/2019 |
GN
| Nuvectra® Terus Mendukung Para Pasien dengan Implan Algovita® Saat Perusahaan Tersebut dengan Sukarela Mengajukan Perlindungan Bab 11 |
| 11/13/2019 |
GN
| ??????11???????????????????Algovita® Implant????????????? |
| 11/13/2019 |
GN
| Nuvectra®, ????? 11? ??? ???? ??? ??? ??, ?? Algovita® ?? ?? ?? ???? ????? ??? ?? |
| 11/13/2019 |
GN
| Nuvectra® Terus Menyokong Pesakit Semasa dengan Implan Algovita® sementara Syarikat Memfailkan Bab 11 secara Sukarela |
| 11/13/2019 |
GN
| Nuvectra® continua a apoiar seus pacientes com o Implante Algovita® enquanto a empresa entra com pedido de recuperação judicial |
| 11/13/2019 |
GN
| Nuvectra® continúa apoyando a los pacientes existentes con el implante Algovita®, mientras la Compañía presenta petición de reestructuración voluntaria bajo el Capítulo XI |
| 11/13/2019 |
GN
| Nuvectra® ????????????????????????????????????????????????????????? Algovita® ??????????????????????????????????????????????????? 11 |
| 11/12/2019 |
GN
| Nuvectra® Continuing to Support Current Patients with the Algovita® Implant as Company Voluntarily Files for Chapter 11 |
| 09/20/2019 |
GN
| Nuvectra® Appoints Jennifer Kosharek as Chief Financial Officer |
| 08/26/2019 |
GN
| Nuvectra® Exploring Strategic Options to Enhance Shareholder Value |
| 07/17/2019 |
GN
| Nuvectra to Report Second Quarter 2019 Financial Results on July 31, 2019 |
| 06/12/2019 |
GN
| Nuvectra® to Participate in Two Upcoming Investor Conferences |
| 06/11/2019 |
GN
| Nuvectra Files Regulatory Submission with FDA for Algovita® Full-Body MR-Conditional Approval |
| 05/30/2019 |
GN
| Nuvectra Highlights Positive Preliminary Algovita® Clinical Data at the INS 14th Annual World Congress |
| 05/16/2019 |
GN
| Nuvectra® Announces Departure of COO & CFO Walter Z. Berger |
| 05/01/2019 |
GN
| Nuvectra® Reports First Quarter 2019 Financial Results |
| 04/22/2019 |
GN
| Nuvectra to Report First Quarter 2019 Financial Results on May 1, 2019 |
| 04/17/2019 |
GN
| Recent Analysis Shows Nuvectra, Red Lion Hotels, Rave Restaurant Group, Aeglea BioTherapeutics, CPI Aerostructures, and Qumu Market Influences — Renewed Outlook, Key Drivers of Growth |
| 03/25/2019 |
GN
| Nuvectra® Appoints Anthony P. Bihl, III as New Chairman of the Board |
| 02/28/2019 |
GN
| Nuvectra® Reports Fourth Quarter and Full Year 2018 Financial Results |
| 02/26/2019 |
GN
| Nuvectra® to Present at 39th Annual Cowen Healthcare Conference |
| 02/21/2019 |
GN
| The Future Is Now; Med Tech That's Changing Lives |
| 02/19/2019 |
GN
| Nuvectra to Report Fourth Quarter and Full Year 2018 Financial Results on February 28, 2019 |
| 01/07/2019 |
GN
| Nuvectra® Announces Preliminary Unaudited Fourth Quarter and Full Year 2018 Revenue |
| 01/02/2019 |
GN
| Nuvectra Announces Divesture of NeuroNexus Subsidiary |
| 12/12/2018 |
GN
| Nuvectra Receives Full-Body MR-Conditional CE Mark Approval for Algovita® |
| 12/06/2018 |
GN
| Nuvectra Completes 3,000 U.S. Algovita® SCS Implantations |
| 12/03/2018 |
GN
| Nuvectra Receives FDA Head-Only MR-Conditional Approval for Algovita® |
| 10/31/2018 |
GN
| Nuvectra® to Participate in Two Upcoming Investor Conferences |
| 10/22/2018 |
GN
| Nuvectra® to Report Third Quarter 2018 Financial Results on October 29, 2018 |
|
|
|